Lab notebooks could determine who was first to invent a revolutionary gene-editing technology.
Deep brain stimulation could lead to a more effective, self-tuning device for Parkinson’s.
We have the technology to dramatically increase the independence of people with spinal-cord injuries. The problem is bringing it to market and keeping it there.
Genetically engineered bacteria ward off obesity in mice, showing how the microbiome could be used treat chronic diseases in people.
Can deep brain stimulation affect how well and what we remember?
Large genome databases are starting to reveal critical health information—even about people who have not contributed their DNA.
A leading researcher issues a call for pills that deliver a full course of treatment in one swallow.
To motivate healthy behavior, device companies and employers embrace social tools and insights from behavioral science.
Nobel Prize winners raise alarm over genetic engineering of humans.
Peter Thiel was the first large investor in Facebook. Now he’s turning his investing skills to biotechnology.